Cys-C Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.

The Biotime Insulin Rapid Quantitative Test is intended to quantify the concentration of insulin in human serum, plasma, or whole blood samples on the Biotime FIA Analyzer (Semi-automatic/Automatic) by fluorescent immunoassay. -Fluorescence immunoassay For in vitro diagnostic use only. For professional use only.

PROG Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Progesterone (PROG) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

CRP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-reactive proteins (CRP) concentration in human serum, plasma and vein whole blood specimens.

Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.

Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).

TheToxoplasma IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toToxoplasma gondii in human serum.IgG results with this assay are used to indicate past or recent infection withToxoplasma gondii. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recentToxoplasma gondii infections. Toxoplasma IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Toxoplasma gondii infection -For in vitro diagnostic use only. For professional use only.